Developing Vaccines to Combat Pandemic Influenza
Influenza vaccine manufacturers require antigenically relevant vaccine viruses that have good manufacturing properties and are safe to use. In developing pandemic vaccine viruses, reverse genetics has been employed as a rational approach that can also be used effectively to attenuate the highly viru...
Main Authors: | Othmar G. Engelhardt, James S. Robertson |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2010-02-01
|
Series: | Viruses |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4915/2/2/532/ |
Similar Items
-
Vaccine effectiveness in pandemic influenza – primary care reporting (VIPER): an observational study to assess the effectiveness of the pandemic influenza A (H1N1)v vaccine
by: CR Simpson, et al.
Published: (2010-07-01) -
Swine Influenza A Vaccines, Pandemic (H1N1) 2009 Virus, and Cross-Reactivity
by: Ralf Dürrwald, et al.
Published: (2010-06-01) -
Influenza Pandemics: Past, Present and Future
by: Yu-Chia Hsieh
Published: (2006-01-01) -
Original Antigenic Sin and Pandemic (H1N1) 2009
by: Amesh A. Adalja, et al.
Published: (2010-06-01) -
Acceptance of the Pandemic H1N1 Influenza Vaccine by the Public and Health Care Workers
by: Serdar GÜL, et al.
Published: (2010-06-01)